SuperworthHealth Catalyst EPS HCAT
Diluted earnings per share by quarter and over the last twelve months, from 2018.
- Last 12 months, to Jun 30, 2026
- −$3.68
- Latest quarter, Q2 FY26
- −$0.55
- Fiscal year 2025
- −$2.54
Health Catalyst's earnings per share was −$3.68 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.55.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2.54 | n/a |
| FY2024 | −$1.15 | n/a |
| FY2023 | −$2.10 | n/a |
| FY2022 | −$2.66 | n/a |
| FY2021 | −$3.21 | n/a |
| FY2020 | −$2.87 | n/a |
| FY2019 | −$39.98 | n/a |
| FY2018 | −$23.93 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.55 | n/a | −$3.68 | |
| Q1 FY26 | −$1.53 | n/a | −$3.72 | |
| Q4 FY25 | −$1.28 | n/a | −$2.54 | |
| Q3 FY25 | −$0.32 | n/a | −$1.59 | |
| Q2 FY25 | −$0.59 | n/a | −$1.51 | |
| Q1 FY25 | −$0.35 | n/a | −$1.15 | |
| Q4 FY24 | −$0.33 | n/a | −$1.15 | |
| Q3 FY24 | −$0.24 | n/a | −$1.35 | |
| Q2 FY24 | −$0.23 | n/a | −$1.50 | |
| Q1 FY24 | −$0.35 | n/a | −$1.85 | |
| Q4 FY23 | −$0.53 | n/a | −$2.10 | |
| Q3 FY23 | −$0.39 | n/a | −$2.23 |
Against its peers
Companies in Software - Application nearest Health Catalyst's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HCATHealth Catalyst | −$3.68 | |
| TRAKReposiTrak | $0.39 | +11% a year |
| ALISCalisa Acquisition | $0.14 | |
| EGHT8X8 | $0.04 | |
| TZOOTravelzoo | $0.03 | −97% a year |
| ZIPZiprecruiter | $0.35 | |
| OOMAOoma | $0.38 | |
| CARSCars.com | $0.57 | −8% a year |
| IBEXIBEX | $3.13 | +31% a year |
| NRDSNerdwallet | $0.89 | +44% a year |
| MNTNMNTN | $0.75 | |
| Peer median | $0.39 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Health Catalyst
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.